Friday, September 13, 2013


Beclo ® NasaI Sprayanti allergic and anti inflammatory composition
Each metered dose contains 50 mcg beclomethasone dipropionate monohydrate equivalent to 42 mcg beclomethasone dipropionate 
Pharmacological properties Beclomethasone dipropionate in Beclo® Nasal Spray is a corticosteroid with mainly glucocorticoid adivity
The therapeutic effects of Beclo® Nasal Spray include
Reduction of mucosal edema
Inhibition of mediators release
Inhibition of inflammatory cell infiltration
Bedo® Nasal Spray provides symptomatic relief of watery rhinorrhea, nasal congestion, sneezing and nasal or pharyngeal itching 
Beclo® Nasal Spray 
is indicated for
1. Prophylaxis & treatment of:
• Seasonal and perennial allergic rhinitis
• Vasomotor (non allergic) rhinitis
2. Prevention of recurrence of nasal polyps
following surgical removal
N.B. Recurrence of symptoms due to polyps can occur after stopping treatment depending on the severity of the disease
>Treatment with higher than recommended
doses for prolonged periods may result in clinically significant adrenal suppression
Care must be taken while transferring patients from systemic steroid to Redo® Nasal Spray if adrenal function is impaired.
Infections of the nasal passages and paranasal sinuses should be appropriately treated but do not constitute a specific contraindication to treatment with Beclo® Nasal Spray
Hypersensitivity to any of the ingredients of this preparation contraindicates its use 
Dosage & administration • Adults and children 12 years of age:
The usual dosage is 2 nasal sprays in each nostril twice daily
• Once adequate control is achieved, the dose is reduced to the lowest effective level, 1 spray in each nostril 3times daily
• Children 6 to 12 years of age:
1 nasal spray in each nostril 3times daily 
How supplied Metered dose nasal spray pump 20 ml containing
200 doses 
Keep all medicaments out of reach of children AMOUN PHARMACEUTICAL Co.
SAE El-Obour City, Cairo, Egypt.

No comments:

Post a Comment